Ronit Juthani, Panah Parab, Kala Seetharaman. "Inclusion of patients with reduced performance status (ECOG 2 or higher) in FDA registrational trials for renal cell carcinoma (RCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.453